[go: up one dir, main page]

LV12966B - The combination of growth hormone and insulin-like growth factor, for treating congestive heart failure - Google Patents

The combination of growth hormone and insulin-like growth factor, for treating congestive heart failure Download PDF

Info

Publication number
LV12966B
LV12966B LVP-02-184A LV020184A LV12966B LV 12966 B LV12966 B LV 12966B LV 020184 A LV020184 A LV 020184A LV 12966 B LV12966 B LV 12966B
Authority
LV
Latvia
Prior art keywords
igf
captopril
heart failure
treatment
congestive heart
Prior art date
Application number
LVP-02-184A
Other languages
English (en)
Latvian (lv)
Inventor
Ross G Clark
Hongkul Jin
Nicholas F Paoni
Renhui Yang
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/284,859 external-priority patent/US5661122A/en
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of LV12966B publication Critical patent/LV12966B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/30—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
LVP-02-184A 1994-04-15 2002-10-15 The combination of growth hormone and insulin-like growth factor, for treating congestive heart failure LV12966B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22792394A 1994-04-15 1994-04-15
US08/284,859 US5661122A (en) 1994-04-15 1994-08-02 Treatment of congestive heart failure
US08/333,909 US5610134A (en) 1994-04-15 1994-11-03 Treatment of congestive heart failure

Publications (1)

Publication Number Publication Date
LV12966B true LV12966B (en) 2003-05-20

Family

ID=27397790

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-02-184A LV12966B (en) 1994-04-15 2002-10-15 The combination of growth hormone and insulin-like growth factor, for treating congestive heart failure

Country Status (12)

Country Link
US (1) US5610134A (fr)
EP (1) EP0755265B1 (fr)
JP (1) JP3473623B2 (fr)
AT (1) ATE208209T1 (fr)
AU (1) AU691273B2 (fr)
CA (1) CA2185998C (fr)
DE (1) DE69523747T2 (fr)
DK (1) DK0755265T3 (fr)
ES (1) ES2167427T3 (fr)
LV (1) LV12966B (fr)
PT (1) PT755265E (fr)
WO (1) WO1995028174A1 (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3182307B2 (ja) * 1994-12-27 2001-07-03 株式会社荏原製作所 全周流型ポンプ
US5741776A (en) * 1995-05-22 1998-04-21 Genentech, Inc. Method of administration of IGF-I
TW432073B (en) 1995-12-28 2001-05-01 Pfizer Pyrazolopyridine compounds
AU2334097A (en) * 1996-03-21 1997-10-10 Merck & Co., Inc. 4-spiroindoline piperidines promote release of growth hormone
US6306826B1 (en) 1997-06-04 2001-10-23 The Regents Of The University Of California Treatment of heart failure with growth hormone
US6015384A (en) * 1998-08-31 2000-01-18 Acuson Corporation Ultrasonic system and method for tissue viability imaging
SE9901634D0 (sv) * 1999-05-05 1999-05-05 Sahltech Ab Treatment of myocardial infarction with a substance related to the growth hormone axis
MXPA02000404A (es) * 1999-07-12 2004-05-21 Grandis Biotech Gmbh Formulaciones de hormona de crecimiento.
AU6085700A (en) * 1999-07-12 2001-01-30 Genentech Inc. Promotion or inhibition of angiogenesis and cardiovascularization by tumor necrosis factor ligand/receptor homologs
WO2001059100A2 (fr) * 2000-02-11 2001-08-16 Genentech, Inc. Nouvel inhibiteur de l'activateur du facteur de croissance des hepatocytes, utile pour moduler l'angiogenese et la cardiovascularisation
FR2805051B1 (fr) * 2000-02-14 2002-12-06 Geophysique Cie Gle Methode de surveillance sismique d'une zone souterraine par utilisation simultanee de plusieurs sources vibrosismiques
EP2275549A1 (fr) 2000-06-23 2011-01-19 Genentech, Inc. Compositions et procédés pour le traitement et le diagnostic des troubles impliquant une angiogénèse
CA2648048A1 (fr) 2000-06-23 2002-01-03 Genentech, Inc. Compositions et procedes de diagnostic et de traitement de troubles dont l'angiogenese
RU2298415C2 (ru) * 2000-07-11 2007-05-10 Сандоз Аг Композиции, включающие гормон роста
US7547674B2 (en) * 2001-06-06 2009-06-16 New York Medical College Methods and compositions for the repair and/or regeneration of damaged myocardium
US7862810B2 (en) 2000-07-31 2011-01-04 New York Medical College Methods and compositions for the repair and/or regeneration of damaged myocardium
US20020061587A1 (en) 2000-07-31 2002-05-23 Piero Anversa Methods and compositions for the repair and/or regeneration of damaged myocardium
US20030224984A1 (en) * 2001-06-20 2003-12-04 Genentech, Inc. Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
US6607517B1 (en) 2001-08-24 2003-08-19 Radiant Medical, Inc. Method of inotropic treatment of heart disease using hypothermia
BR0317888A (pt) 2002-12-31 2005-12-06 Altus Pharmaceuticals Inc Cristais do hormÈnio do crescimento humano e processos para preparação dos mesmos
EP1841443A4 (fr) * 2005-01-11 2012-05-02 Heart Failure Technologies Inc Methode et systeme pour le traitement de l'insuffisance cardiaque
AU2008323719B2 (en) 2007-11-09 2013-04-04 New York Medical College Methods for the repair and/or regeneration of damaged myocardium using variants of hepatocyte growth factor
US8512696B2 (en) 2007-11-30 2013-08-20 Autologous, Llc Methods of isolating non-senescent cardiac stem cells and uses thereof
EP2227238A2 (fr) 2007-11-30 2010-09-15 New York Medical College Compositions comprenant des cellules progénitrices vasculaires et myocytaires et procédés permettant de les utiliser
CA2743682A1 (fr) 2007-11-30 2009-06-11 New York Medical College Procedes permettant de reduire le rejet de greffon et l'arteriosclerose acceleree du greffon cardiaque par implantation de cellules souches autologues

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5126324A (en) * 1990-06-07 1992-06-30 Genentech, Inc. Method of enhancing growth in patients using combination therapy
WO1992007578A1 (fr) * 1990-10-25 1992-05-14 Genentech, Inc. Utilisation d'agents protecteurs contre des especes d'oxygene reactives
SE9100099D0 (sv) * 1991-01-11 1991-01-11 Kabi Pharmacia Ab Use of growth factor
SE9101840L (sv) * 1991-06-14 1992-12-15 Kabi Pharmacia Ny medicinsk anvaendning
US5202119A (en) * 1991-06-28 1993-04-13 Genentech, Inc. Method of stimulating immune response
WO1993000109A1 (fr) * 1991-06-28 1993-01-07 Genentech, Inc. Procede de stimulation de la reponse immunitaire a l'aide d'hormone de croissance

Also Published As

Publication number Publication date
AU691273B2 (en) 1998-05-14
HK1003418A1 (en) 1998-10-30
ES2167427T3 (es) 2002-05-16
JP3473623B2 (ja) 2003-12-08
WO1995028174A1 (fr) 1995-10-26
AU2195695A (en) 1995-11-10
PT755265E (pt) 2002-04-29
DE69523747D1 (de) 2001-12-13
DK0755265T3 (da) 2002-03-04
EP0755265A1 (fr) 1997-01-29
DE69523747T2 (de) 2002-08-01
CA2185998C (fr) 2011-02-22
US5610134A (en) 1997-03-11
JPH09512008A (ja) 1997-12-02
EP0755265B1 (fr) 2001-11-07
CA2185998A1 (fr) 1995-10-26
ATE208209T1 (de) 2001-11-15

Similar Documents

Publication Publication Date Title
AU691273B2 (en) The combination of growth hormone and insulin-like growth factor, for treating congestive heart failure
CA2185999C (fr) Traitement de l'insuffisance cardiaque congestive
US5661122A (en) Treatment of congestive heart failure
EP0536226B1 (fr) Combinaison de l'hormone de croissance et du facteur de croissance de type i proche de l'insuline pour ameliorer la croissance
EP0754048B1 (fr) Traitement du syndrome d'insensibilite partielle a l'hormone de croissance
US6509443B1 (en) IGF-I point variants
US6902744B1 (en) Exendin agonist formulations and methods of administration thereof
US5216004A (en) Method for preventing malaria
US20090088380A1 (en) Ghrh analogs and therapeutic uses thereof
HK1007954B (en) The combination of growth hormone and insulin-like growth factor-i enhances growth
CA2001897A1 (fr) Methode pour augmenter le taux d'hemoglobine du foetus par traitement avec de l'activine et/ou de l'inhibitine
US5824642A (en) Treatment of partial growth hormone insensitivity syndrome
JP2001501177A (ja) Ｏｂタンパク質受容体をアップレギュレートすることによりｏｂタンパク質に対する個体の感受性を増加させる方法
US5700776A (en) Medicaments comprising glicentin as active ingredient
HK1003418B (en) The combination of growth hormone and insulin-like growth factor, for treating congestive heart failure
MXPA96004803A (en) Combination of hormone of growth and factor similar decrease to insulin for the treatment of the cardiac failure congest
JP2001226284A (ja) 神経突起誘発剤
MXPA96004802A (en) Treatment of cardiac failure congest